Please login to the form below

Not currently logged in
Email:
Password:

miRagen Therapeutics

This page shows the latest miRagen Therapeutics news and features for those working in and with pharma, biotech and healthcare.

Oncology bias in pharma deals

disease) to Newron Pharmaceuticals, triggered the termination of Biotie Therapeutics' acquisition of Newron. ... 370. miRagen Therapeutics/Servier. R&D and commercialisation licence (option to co-sponsor phase III).

Latest news

  • RNA interference rebirth RNA interference rebirth

    Initial enthusiasm for therapeutics based on RNA interference (RNAi), commonly referred to as gene silencing, faced some setbacks in 2010 after some late-stage trial failures and the withdrawal of Roche ... An emerging group of companies, notably Regulus

  • Pfizer expands RNA development deal

    Santaris, which was founded in 2003, also has strategic partnerships with miRagen Therapeutics (targeting cardiovascular disease), Shire (aimed at rare genetic disorders), GlaxoSmithKline (aimed at viral diseases), and Enzon Pharmaceuticals (for

More from news
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest Intelligence

  • Pharma deals during April 2013 Pharma deals during April 2013

    respectively. As a result, companies with ADC capabilities, such as Ambrx, Mersana Therapeutics and ImmunoGen, are becoming popular partner targets for pharma companies. ... Santaris/ BMS. April also saw the announcement of yet another Santaris deal,

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

  • miRagen Therapeutics bolsters senior leadership team miRagen Therapeutics bolsters senior leadership team

    Meanwhile, Mori (pictured below) brings over 25 years of strategic and operational experience to his new role at miRagen Therapeutics. ... I am excited to join this talented team and contribute to the success of miRagen Therapeutics as we develop our

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Origins Insights

Origins are part of the Resonant Group. Using novel research methodologies, we dig deeper to deliver authentic audience experiences that...

Latest intelligence

Animation: Living With
The journey from the patient's perspective...
Danny Buckland July2022
Achieving communication excellence by targeting the right channel at the right time
By Danny Buckland...
6 trends shaping the future of personalized medicine
Senior Consultant Leah Carlisle explores the key trends discussed at the 16th annual Personalized Medicine Conference, providing expert analysis and key recommendations for biopharmaceutical innovators....